Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion type Assertion NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_head.
- NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion description "[Uni- and multivariable analyses for recurrence and progression were performed using clinicopathological variables, T1 sub-stage, EORTC risk scores and molecular markers (fibroblast growth factor receptor 3 gene mutation and Ki-67, P53, P27 expression).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_provenance.
- NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion evidence source_evidence_literature NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_provenance.
- NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion SIO_000772 22448597 NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_provenance.
- NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion wasDerivedFrom befree-20140225 NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_provenance.
- NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_assertion wasGeneratedBy ECO_0000203 NP534415.RACgduf1oh3K4LADKSUDTUNN5E2Bak3E-NJvnG7jNkCxI130_provenance.